Amrutanjan Health targets 100,000 direct chemist outlets in FY27

After adding 44,000 chemist outlets in FY26, Amrutanjan Health Care is targeting 100,000 direct outlets in FY27 as it expands beyond its southern and eastern strongholds. FY26 revenue rose 11.23% to ₹502.55 crore, while net profit grew nearly 14% to ₹57.92 crore.

— Source publishedSun, 30 Aug, 2026, 10:49 IST·First seen Sun, 30 Aug, 2026, 10:58 IST·Source The Hindu BusinessLine

What happened

Amrutanjan Health Care targets 1 lakh direct chemist outlets in FY27 after adding 44,000 in FY26. It is expanding beyond southern and eastern strongholds,

Key facts

  • Target of 1,00,000 direct chemist outlets in FY27
  • 44,000 new chemist outlets added in FY26
  • FY26 revenue from operations up 11.23% to ₹502.55 crore
  • FY26 net profit up nearly 14% to ₹57.92 crore
  • Over 650 employees
  • Pain-management category gross sales grew 10% in FY26
  • Headache category grew 8%; body-ache category grew 16%
  • Comfy ranks fourth nationally in mass pad segment
  • 70% of critical processes automated, targeted near 100%

Why this matters

The national chemist-outlet ambition could make regional distribution partnerships or acquisitions attractive to accelerate entry into underpenetrated western and northern markets.

What to watch

  • Quarterly disclosure of active direct chemist outlets versus cumulative signed outlets.
  • Revenue growth in FY27 relative to FY26's 11.23% increase.
  • Gross margin, employee expense, selling expense and trade-promotion trends.
  • Growth contribution from western and northern regions and evidence of reduced geographic concentration.
  • Inventory days, receivable days and operating cash-flow conversion as direct coverage scales.
  • New product launches and proportion of sales from non-core health-and-wellness categories.
  • Competitive response from larger OTC and consumer-health companies through retailer incentives or price promotions.
  • Add regional sales personnel, distributors and direct-servicing infrastructure in western and northern India.
  • Increase chemist-focused trade schemes, point-of-sale visibility and retailer engagement to secure shelf space.
  • Prioritize high-velocity OTC products such as pain balm, headache remedies and cold-relief products to build outlet productivity.
  • Use the enlarged direct network to launch or broaden adjacent health-and-wellness SKUs.
  • Track outlet activation, repeat ordering and revenue per outlet rather than headline distribution additions alone.